8.01
전일 마감가:
$8.36
열려 있는:
$8.31
하루 거래량:
98,796
Relative Volume:
0.58
시가총액:
$217.36M
수익:
$56.13M
순이익/손실:
$-14.67M
주가수익비율:
-10.82
EPS:
-0.74
순현금흐름:
$-9.13M
1주 성능:
+10.18%
1개월 성능:
+1.65%
6개월 성능:
+11.25%
1년 성능:
+111.35%
Journey Medical Corp Stock (DERM) Company Profile
명칭
Journey Medical Corp
전화
480-434-6670
주소
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
DERM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DERM
Journey Medical Corp
|
8.01 | 226.86M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | H.C. Wainwright | Buy |
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | ROTH MKM | Buy |
| 2021-12-07 | 개시 | B. Riley Securities | Buy |
Journey Medical Corp 주식(DERM)의 최신 뉴스
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Can Tenon Medical Inc. Equity Warrant stock hit record highs againJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
Why Orthofix Medical Inc. (OM2) stock is upgraded to buyAnalyst Upgrade & Safe Capital Growth Tips - Улправда
IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship' - Yahoo Finance
Best Medical Travel Insurance Companies of 2026 - U.S. News & World Report
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
10 Best Travel Insurance Companies For 2026 - Forbes
The Truth About Journey Medical Corp (DERM): Tiny Stock, Big Drama – Is It Worth the Hype? - AD HOC NEWS
Layoff Tracker: Nido Will Close Following Lead Candidate’s Disappointing Phase II Results - BioSpace
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Can Zhejiang Taimei Medical Technology Co. Ltd. (A2V) stock ride next bull market cycleMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
Can Unidoc Health Corp. (L7T) stock beat analyst consensusJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - Улправда
Is Journey Medical Corporation stock a buy on dipsEarnings Miss & Technical Analysis for Trade Confirmation - Улправда
How analysts rate Quipt Home Medical Corp. stock todayWeekly Gains Report & Accurate Trade Setup Notifications - Улправда
Fortress Biotech (Nasdaq: FBIO): FDA accepts Class 1 resubmission, CUTX-101 PDUFA Jan. 14, 2026 - Stock Titan
Journey Medical announces results from phase 1 trial of DFD-29 - MSN
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Minocycline study shows no microbiome disruption after 16-week use By Investing.com - Investing.com Nigeria
Journey Medical announces results from Phase 1 trial of DFD-29 - TipRanks
DERM FinancialsIncome Statement - Quiver Quantitative
Minocycline study shows no microbiome disruption after 16-week use - Investing.com India
Journey Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety Issues - Quiver Quantitative
Journey Medical (Nasdaq: DERM) posts Phase 1 Emrosi data on 16-week microbiome profile - Stock Titan
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - Yahoo Finance
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis - TradingView — Track All Markets
DERM Stock On The Rise: Worth Watching As Emrosi Adoption Expands - RTTNews
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Medical Corp (DERM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):